BMS236 Integrated Pharmacology and Pathophysiology for Allied Health Practice (8)

In this subject, students will apply their foundational knowledge of pathophysiological and pharmacological principles to analyse the neurological, endocrine, digestive, integumentary and musculoskeletal systems. Students will also extend their knowledge of pathopharmacology in relation to chronic disease, with a focus on genetic disorders, cancer, diabetes and infection.

Availability

Session 2 (60)
Online
Albury-Wodonga Campus

Continuing students should consult the SAL for current offering details: BMS236. Where differences exist between the Handbook and the SAL, the SAL should be taken as containing the correct subject offering details.

Subject Information

Grading System

HD/FL

Duration

One session

School

School of Community Health

Assumed Knowledge

Foundational knowledge of physiology and principles of pharmacology.

Incompatible Subjects

BMS250

Learning Outcomes

Upon successful completion of this subject, students should:
  • be able to differentiate between a healthy neurological, endocrine, digestive, integumentary and musculoskeletal system and one impacted by disease
  • be able to explain the mechanism of action and properties of medicines used for the treatment of neurological, endocrine, gastrointestinal, cutaneous and musculoskeletal pathology
  • be able to evaluate the pharmacological management of chronic disease
  • be able to explain the pharmacological basis supporting treatment decisions in allied health practice

Syllabus

This subject will cover the following topics:
  • Genes and genetic disorders
  • Neurophysiology / neuropharmacology / pharmacology for psychological disorders
  • Endocrine pathophysiology & pharmacology: thyroid dysfunction
  • Infection / antimicrobial Agents
  • Haematology / haematological pharmacology
  • Pharmacology for cutaneous pathology
  • Musculoskeletal pathophysiology & pharmacology
  • Digestive function / GI pharmacology
  • The impact of chronic stress and contemporary health issues
  • Cancer and chemotherapy treatments

Indicative Assessment

The following table summarises the assessment tasks for the online offering of BMS236 in Session 2 2020. Please note this is a guide only. Assessment tasks are regularly updated and can also differ to suit the mode of study (online or on campus).

Item Number
Title
Value %
1
Weekly mini tests
0
2
Mid-session assignment
50
3
Final exam
50

The information contained in the CSU Handbook was accurate at the date of publication: February 2021. The University reserves the right to vary the information at any time without notice.

Back